| Literature DB >> 33642743 |
Saif Khan1, Kafil Akhtar2, Abdul Ahad3, Jaiti Uppal1.
Abstract
Necrotizing ulcerative periodontitis (NUP) is a painful and debilitating condition seen mostly in an immunocompromised state. Although squamous cell carcinoma (SCC) on gingiva is not uncommon, its presentation as a benign necrotizing lesion on gingiva is rare. Such presentations may lead to delayed diagnosis and poor prognosis. This report describes a case of a 34-year-old male presenting clinically with NUP around mandibular posterior teeth. Clinical features were misleading, but the histological findings established the diagnosis of well-differentiated SCC. Immunohistochemistry also showed features of epithelial-mesenchymal transition with decreased expression of E-cadherin and increased vimentin expression showing local invasion and metastasis. The patient was referred to the oncology department for evaluation of possible metastasis and further management of carcinoma. Copyright:Entities:
Keywords: Gingiva; immunohistochemistry; periodontal disease; squamous cell carcinoma
Year: 2020 PMID: 33642743 PMCID: PMC7904020 DOI: 10.4103/jisp.jisp_175_20
Source DB: PubMed Journal: J Indian Soc Periodontol ISSN: 0972-124X
Figure 1Clinical picture showing severely inflamed gingiva with necrosis of interdental papilla between right second mandibular premolar and first molar. The lesion can be seen extending from the mesiobuccal aspect of the first premolar to the distal aspect of the first molar
Figure 2Periapical radiograph of the involved region showing severe loss of alveolar bone around #45 and #46
Figure 3Well-differentiated squamous cell carcinoma: Tissue section showed clusters of atypical large polygonal tumor cells with a hyperchromatic nucleus, prominent nucleoli, irregular nuclear membranes, and well-defined eosinophilic cytoplasm, with keratin pearl formation. H and E, ×40
Figure 4The decreased intensity of membranous staining in tumor cells (1+). Immunohistochemistry E-cadherin, ×40
Figure 5Mild focal cytoplasmic positivity in tumor cells (1+). Immunohistochemistry Vimentin, ×40